80 to 84-year-olds invited for vaccination sooner Starting tomorrow, the first people in the age group from 80-84 years in the Netherlands will receive an invitation from RIVM for a COVID-19 vaccination.
New variants disrupt plans In the past week, from 27 January to 2 February, 28,628 people in the Netherlands reportedly tested positive for COVID-19, a 20% decrease compared to the week of 20 to 26 January.
One person died shortly after COVID-19 vaccination The Pharmacovigilance Centre Lareb announced today that the centre had received a report of death shortly after receiving the Pfizer/BioNTech COVID-19 vaccination in the Netherlands.
Nationwide assessment of SARS-CoV-2 laboratories: very high quality The vast majority of the laboratories analysing COVID-19 tests are performing at the very highest standard of quality.
RIVM launches study on coronavirus herd immunity RIVM has launched a large-scale study to investigate how many people have antibodies for the novel coronavirus (COVID-19).
Novel coronavirus found in wastewater The novel coronavirus that causes COVID-19 has been detected in wastewater in the Netherlands, according to RIVM research.
A decrease in the number of tuberculosis patients in the Netherlands In 2019, the number of people with tuberculosis (TB) in the Netherlands decreased to 759. This is 5 per cent less than in 2018, when 797 were reported.
Population screening programmes temporarily on hold Due to the novel coronavirus (COVID-19) outbreak, the health care capacity in the Netherlands is expected to come under severe pressure in the coming period.
Additional measures novel coronavirus COVID-19 RIVM has advised the Dutch government that additional measures are needed throughout the Netherlands to prevent the spread of COVID-19.
Results of random sample test: 4% of hospital staff infected with coronavirus Nearly four per cent of the hospital staff examined in Brabant is infected with the novel coronavirus (COVID-19). A random sample test by RIVM between 6 and 9 March reveals this.